Skip to main content
. Author manuscript; available in PMC: 2011 Feb 15.
Published in final edited form as: Toxicol Lett. 2009 Dec 1;192(3):387. doi: 10.1016/j.toxlet.2009.11.016

Fig. 8. Release of HMGB1 into the cellular supernatant of APAP-treated TAMH cells.

Fig. 8

TAMH cells were treated with APAP (0, 1, 10 or 30 mM) for 15 hr. Following treatment, cellular supernatant was collected, concentrated and residual APAP was removed via a desalting column. (A) Immunoblot analysis of HMGB1 release into the cellular supernatant. (B) Quantification of HMGB1 release into the cellular supernatant by densitometry. *, P < 0.05, compared with cells treated with 0 mM APAP.